139 GBR1302: a BEAT® bispecific antibody for the treatment of HER2 positive cancers
Croset, A, Macoin, J, Ollier, R, Pluess, M, Delon, C, Skegro, D, Blein, S, Hou, S, Back, J
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
558 Preclinical profile of STAR-0310, a novel OX40 antagonistic monoclonal antibody
Zhao, C., Macoin, J., Carretero, L., Biris, N.
Published in Journal of investigative dermatology (01.08.2024)
Published in Journal of investigative dermatology (01.08.2024)
Get full text
Journal Article
1100 Targeting OX40 with GBR 830, an OX40 antagonist, inhibits T cell-mediated pathological responses
Macoin, J., Lissilaa, R., Sancheti, P., Reddy, V., Back, J.
Published in Journal of investigative dermatology (01.05.2018)
Published in Journal of investigative dermatology (01.05.2018)
Get full text
Journal Article
1099 GBR 830: An OX40 antagonist antibody with a favorable toxicity profile in non-human primates
Macoin, J., Blein, S., Monney, T., Lissilaa, R., Sancheti, P., Reddy, V., Back, J.
Published in Journal of investigative dermatology (01.05.2018)
Published in Journal of investigative dermatology (01.05.2018)
Get full text
Journal Article
453 GBR 830 induces progressive and sustained changes in atopic dermatitis biomarkers in patient skin lesions
Guttman-Yassky, E., Pavel, A.B., Estrada, Y., Zhou, L., Salhi, Y., Gudi, G., A, V.C., Macoin, J., Back, J., Grossman, F., Wolff, G.
Published in Journal of investigative dermatology (01.05.2018)
Published in Journal of investigative dermatology (01.05.2018)
Get full text
Journal Article